ViroPharma Incorporated VPHM today announced the U.S. Food and Drug Administration (FDA) has approved
the supplement to the Cinryze Biologics License Application (BLA) for
industrial scale manufacturing changes. As previously announced, the company
expects completion of labeling for previously produced vials to take
approximately six weeks before entering into the trade.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in